The Texas Medical Center is the largest medical complex in the world — more than 60 institutions packed into a few square miles of Houston, with millions of patient encounters a year. It is also, quietly, one of the most concentrated proving grounds for surgical robotics anywhere on earth. From the workhorse robotic systems running thousands of procedures a year to a Houston startup pioneering surgery with no incisions at all, the TMC is where a remarkable amount of the field's present and future is being worked out.

This is a guide to what surgical robotics actually is, the systems in use across Houston, and the frontier being pushed right here.

What "Surgical Robotics" Actually Means

The first thing to understand is that a surgical robot does not operate on its own. The dominant model today is teleoperation: a surgeon sits at a console a few feet from the patient, looking into a magnified 3D high-definition view of the surgical site, and moves hand controls that translate their movements into the motions of tiny instruments inside the body. The robot is, in effect, a very precise extension of the surgeon's hands — not a replacement for the surgeon.

What the robot adds is mechanical capability a human hand can't match. The instruments are wristed, meaning they bend and rotate far beyond the range of a human wrist, and they filter out the natural tremor in a surgeon's hands. Combined with the magnified 3D vision, this lets surgeons perform complex procedures through openings a few millimeters wide instead of large incisions. For patients, minimally invasive surgery generally means less blood loss, less pain, lower infection risk, and faster recovery.

The Workhorse: da Vinci Across the TMC

The system most people mean when they say "surgical robot" is the da Vinci, made by Intuitive Surgical. It is the established standard, and the Texas Medical Center runs it at scale across multiple institutions.

Memorial Hermann's Surgical Innovation and Robotics Institute (SIRI) at the TMC has been operating since 2003 and is one of the largest robotic surgery sites in the nation. Affiliated surgeons there have performed thousands of robotic procedures across specialties including gynecology, general surgery, bariatrics, urology, pediatric urology, and surgical oncology — and, just as importantly, SIRI has trained thousands of surgeons from around the world. That training role is part of what makes Houston a center of gravity for the field: surgeons fly in to learn robotic technique and carry it back to their own institutions.

Houston Methodist is another major player, with a particular reputation in robotic urology and a Division of Surgical Innovation whose scope spans surgical robotics, reconstructive innovation, and 3D biofabrication. The hospital launched the first robotic vascular surgery program in the U.S. and has been a pioneer in using robotics for procedures like retroperitoneal lymph node dissection in testicular cancer.

At MD Anderson Cancer Center, robotics is woven into the world's largest surgical-oncology practice. MD Anderson performs more procedures than any other National Cancer Institute-designated comprehensive cancer center, with robotic systems supporting gynecologic, thoracic, urologic, and general surgical cancer cases. When the question is removing a tumor with millimeter precision while sparing healthy tissue, the robot's stability and dexterity are a direct clinical advantage.

The reach extends beyond the headline institutions. The Michael E. DeBakey VA Medical Center in Houston recently became the first VA hospital in the country to implement the new da Vinci 5 system — bringing the latest generation of the technology to veterans — and Harris Health's Lyndon B. Johnson Hospital uses da Vinci for procedures like hernia repair, putting robotic surgery within reach of the region's safety-net patients.

The Frontier: Surgery With No Incision at All

If da Vinci represents the established present of surgical robotics, a Houston startup is building one of its more radical futures. EndoQuest Robotics is developing flexible robotics for endoluminal surgery — operating inside the body through its natural openings, with no external incision whatsoever.

The idea is to thread a flexible robotic system through the gastrointestinal tract to remove early-stage lesions and tumors from the inside, a procedure category that today demands extraordinary manual skill from a handful of specialists. EndoQuest's Endoluminal Surgical (ELS) System aims to make these procedures more controllable and more widely performable by giving the operator robotic precision instead of relying on hand-manipulated flexible scopes.

This is not a concept on a whiteboard. EndoQuest's pivotal PARADIGM trial — a multicenter U.S. study under an FDA Investigational Device Exemption — has been evaluating the ELS system in lower-GI procedures performed by both colorectal surgeons and gastroenterologists. In January 2026 the FDA approved initiation of the trial's final stage, and the study enrolled patients across five leading institutions including HCA Healthcare in Houston, Mayo Clinic, Cleveland Clinic, Brigham and Women's Hospital, and AdventHealth. Along the way, the technology was used in what was described as the world's first fully robotic endoscopic submucosal dissection (ESD) procedures performed as part of an IDE trial. On completion, EndoQuest plans to submit an FDA de novo request — the regulatory pathway for a genuinely new category of device.

The company has drawn real investor confidence, reportedly reaching a valuation north of $300 million. For Houston, EndoQuest represents something the city's medical-robotics scene has needed: not just a place that uses surgical robots, but a place that builds them.

Why the TMC Is Such a Strong Proving Ground

A few structural advantages make Houston unusually well suited to surgical robotics. The first is sheer volume — the concentration of high-acuity surgical cases at institutions like MD Anderson and Memorial Hermann generates the procedure counts needed to refine technique, train surgeons, and gather the clinical evidence that regulators and hospitals demand.

The second is the training infrastructure. When one campus has trained thousands of robotic surgeons, the expertise compounds. New systems get adopted faster, surgeons collaborate across institutions, and startups can find experienced clinical partners to test new devices.

The third is the proximity of clinicians and developers. EndoQuest's existence in Houston is not a coincidence — building a surgical robot requires constant feedback from surgeons who will actually use it, and the TMC puts those surgeons within driving distance. It's the same dynamic that makes the offshore-energy cluster good at subsea robotics, applied to medicine.

What Comes Next

The near-term trajectory is more of everything: newer da Vinci generations rolling out across TMC institutions, more specialties adopting robotic approaches, and the gradual expansion of robotics into safety-net and veterans' care so the benefits aren't limited to flagship hospitals. The longer-term frontier — incisionless endoluminal surgery, greater automation of routine sub-tasks, and AI-assisted guidance during procedures — is being actively shaped by work happening in Houston right now.

For a city that often gets cast purely as an energy town, the Texas Medical Center is a reminder that Houston's robotics story is just as much about operating rooms as it is about oil rigs. Explore the Texas Medical Center and other Houston medical-robotics organizations in our company directory, or browse our latest coverage.